- Home
- Publications
- Publication Search
- Publication Details
Title
Advances and challenges in the treatment of esophageal cancer
Authors
Keywords
Drug combination, Esophageal adenocarcinoma, Esophageal squamous cell carcinoma, Immune therapy, Molecular targeted therapy
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-10
DOI
10.1016/j.apsb.2021.03.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
- (2020) Svenja Wagener-Ryczek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Long Non-Coding RNA KLF3-AS1 Suppresses Cell Migration and Invasion in Esophageal Squamous Cell Carcinoma by Impairing miR-185-5p-targeted KLF3 Inhibition
- (2020) Jun-Qi Liu et al. Molecular Therapy-Nucleic Acids
- RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma
- (2020) Zhaoming Lu et al. Acta Pharmaceutica Sinica B
- TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
- (2020) Hideaki Bando et al. BMC CANCER
- LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation
- (2020) Rui Cai et al. Journal of Translational Medicine
- Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
- (2020) Afsheen Raza et al. Journal of Translational Medicine
- Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma
- (2020) Shinya Ohashi et al. MOLECULAR CANCER THERAPEUTICS
- TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ
- (2020) Sha Zhou et al. ONCOGENE
- Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients
- (2020) H. Daiko et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
- (2019) Yujie Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression
- (2019) Yunzhao Chen et al. Molecular Cancer
- Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762
- (2019) Jing-Nan Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Etiology, Cancer Stem cells and Potential Diagnostic Biomarkers for Esophageal Cancer
- (2019) Kuancan Liu et al. CANCER LETTERS
- CACNA2D3 Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin via Inducing Ca2+-Mediated Apoptosis and Suppressing PI3K/Akt Pathways
- (2019) Changjun Nie et al. Frontiers in Oncology
- A good start of immunotherapy in esophageal cancer
- (2019) Qian Zhao et al. Cancer Medicine
- Dual effects of an anti-CD147 antibody for Esophageal cancer therapy
- (2019) Miao Wang et al. CANCER BIOLOGY & THERAPY
- Immune checkpoint inhibitors: a new era for esophageal cancer
- (2019) Li-Qing Zou et al. Expert Review of Anticancer Therapy
- The emerging use of immune checkpoint blockade in the adjuvant setting for solid tumors: a review
- (2019) Elissar Moujaess et al. Immunotherapy
- Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma
- (2019) Md. Sazzad Hassan et al. Scientific Reports
- PD-1 Inhibitors in the Advanced Esophageal Cancer
- (2019) Ye Hong et al. Frontiers in Pharmacology
- MicroRNA-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo
- (2019) Chengliang Yang et al. Molecular Therapy-Nucleic Acids
- Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
- (2019) Pei-Wen Yang et al. Frontiers in Oncology
- Protective and anticancer effects of orange peel extract and naringin in doxorubicin treated esophageal cancer stem cell xenograft tumor mouse model
- (2019) Mahboubeh Tajaldini et al. BIOMEDICINE & PHARMACOTHERAPY
- Esophageal carcinoma: Towards targeted therapies
- (2019) Ali Fatehi Hassanabad et al. CELLULAR ONCOLOGY
- Lapatinib in combination with paclitaxel plays synergistic antitumor effects on esophageal squamous cancer
- (2018) Xiao-fang Guo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1
- (2018) Xiao-Ping Huang et al. CANCER LETTERS
- Targeting Orai1-mediated store-operated calcium entry by RP4010 for anti-tumor activity in esophagus squamous cell carcinoma
- (2018) Chaochu Cui et al. CANCER LETTERS
- The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma
- (2018) Qi Shi et al. CANCER LETTERS
- Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma
- (2018) Dongxi Hong et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/β-catenin signaling pathway
- (2018) Hongyu Yuan et al. EXPERIMENTAL CELL RESEARCH
- Insights Into the Pathophysiology of Esophageal Adenocarcinoma
- (2018) Michael Quante et al. GASTROENTEROLOGY
- Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8+ T cell response in esophageal squamous cell carcinoma
- (2018) Xinfeng Chen et al. INTERNATIONAL JOURNAL OF CANCER
- ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer
- (2018) David Vrana et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
- (2018) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma
- (2018) Ting-Ting Liu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
- (2018) Md Sazzad Hassan et al. Translational Oncology
- Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
- (2018) Yun Che et al. Cell Death & Disease
- A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
- (2018) Jianling Zou et al. Cell Death & Disease
- Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
- (2018) Ying-Ya Cao et al. Cell Death & Disease
- Hesperetin inhibits Eca-109 cell proliferation and invasion by suppressing the PI3K/AKT signaling pathway and synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal cancer in vitro and in vivo
- (2018) Dandan Wu et al. RSC Advances
- Epithelial-mesenchymal transition-converted tumor cells can induce T-cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma
- (2018) Aung Kyi Thar Min et al. Cancer Medicine
- EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma
- (2018) Hui Shi et al. Journal of Thoracic Disease
- Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer
- (2018) Kai Lin et al. FASEB JOURNAL
- Doxorubicin-loaded poly(ε-caprolactone)-Pluronic micelle for targeted therapy of esophageal cancer
- (2018) Shujun Dai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA
- (2018) Min Kang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mouse avatar models of esophageal squamous cell carcinoma proved the potential for EGFR-TKI afatinib and uncovered Src family kinases involved in acquired resistance
- (2018) Zhentao Liu et al. Journal of Hematology & Oncology
- Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation
- (2018) Hoi Yan Ng et al. Translational Oncology
- Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways
- (2018) Jinlin Cao et al. Cell Death & Disease
- Genetic and pharmacological inhibition of eIF4E effectively targets esophageal cancer cells and augments 5-FU’s efficacy
- (2018) Jindan Kai et al. Journal of Thoracic Disease
- A subset of esophageal squamous cell carcinoma patient-derived xenografts respond to cetuximab, which is predicted by high EGFR expression and amplification
- (2018) Hanting Zhu et al. Journal of Thoracic Disease
- Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma
- (2018) Jun Hong et al. Molecular Oncology
- An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies
- (2018) Xin-yue Hu et al. Molecular Oncology
- EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
- (2018) Francisco Sanchez-Vega et al. Cancer Discovery
- EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway
- (2018) Yun Yang et al. Journal of Immunology Research
- Promising immunotherapies for esophageal cancer
- (2017) Tomokazu Tanaka et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition
- (2017) Eva A. Ebbing et al. GASTROENTEROLOGY
- Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells
- (2017) Cong Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
- (2017) Li Zhang et al. International Journal of Nanomedicine
- Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells
- (2017) Masahiro Yoshioka et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Dendritic Cell Vaccine Combined With Radiotherapy Activates the Specific Immune Response in Patients With Esophageal Cancer
- (2017) Chengshi Wang et al. JOURNAL OF IMMUNOTHERAPY
- A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
- (2017) Shumei Song et al. MOLECULAR CANCER THERAPEUTICS
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics
- (2017) Chi Zhang et al. ONCOLOGY REPORTS
- Targeting CD47 Enhances the Efficacy of Anti-PD-1 and CTLA-4 in an Esophageal Squamous Cell Cancer Preclinical Model
- (2017) Hua Tao et al. ONCOLOGY RESEARCH
- Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
- (2017) Wencheng Zhang et al. OncoTargets and Therapy
- Immunotherapy for Esophageal Squamous Cell Carcinoma
- (2017) Takashi Kojima et al. Current Oncology Reports
- Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines
- (2017) Elmire Hartmans et al. Oncotarget
- Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450
- (2017) Ping Chen et al. Oncotarget
- Targeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cells
- (2017) Jingyang Zhang et al. Oncotarget
- The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
- (2017) Lin Li et al. Scientific Reports
- Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo
- (2017) Jian-Cai Tang et al. Cancer Research and Treatment
- Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor-κ B signaling in esophageal squamous cell carcinoma
- (2017) Junzhou Wu et al. Cancer Medicine
- miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression
- (2016) Yan Wang et al. ANNALS OF SURGERY
- Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer
- (2016) Maryam Hemmatzadeh et al. BIOMEDICINE & PHARMACOTHERAPY
- The crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A
- (2016) Ranran Kong et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression
- (2016) SEN JIANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC
- (2016) Y. Nakamura et al. MOLECULAR CANCER THERAPEUTICS
- Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma
- (2016) Y-Y Jiang et al. ONCOGENE
- The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
- (2016) J. Antony et al. Science Signaling
- β-Carotene synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal squamous cell carcinoma in vivo and in vitro
- (2016) Yanting Zhang et al. TOXICOLOGY LETTERS
- Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis
- (2016) Xiao-Fei Zhang et al. Oncotarget
- Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro
- (2016) Qinghua Li et al. Oncotarget
- Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines
- (2016) Shota Fukuoka et al. Oncotarget
- The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo
- (2016) Shintaro Fujihara et al. Oncotarget
- Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma
- (2016) Wenqiao Zang et al. Oncotarget
- The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
- (2016) J. Antony et al. Science Signaling
- Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
- (2015) Ling Zhang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis
- (2015) Aaron P. Thrift Clinical Gastroenterology and Hepatology
- Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells
- (2015) Guanghui Cui et al. MEDICAL ONCOLOGY
- Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models
- (2015) Hao Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer
- (2015) Qiongrong Chen et al. Oncotarget
- Elevated Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma
- (2015) Hua Zhu et al. Oncotarget
- Resistance to Cetuximab in EGFR-Overexpressing Esophageal Squamous Cell Carcinoma Xenografts Due to FGFR2 Amplification and Overexpression
- (2014) Yi Zhang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients
- (2014) Hisae Iinuma et al. Journal of Translational Medicine
- Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery
- (2014) Jingchuan Zhang et al. LABORATORY INVESTIGATION
- Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development
- (2014) Mohammad Mahdi Forghanifard et al. MEDICAL ONCOLOGY
- Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer
- (2014) JUN WANG et al. Molecular Medicine Reports
- Esophageal Carcinoma
- (2014) Anil K. Rustgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma
- (2014) JUNHYE KWON et al. ONCOLOGY REPORTS
- STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma
- (2014) Qu Zhang et al. TUMOR BIOLOGY
- Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
- (2013) Shinichi Kageyama et al. Journal of Translational Medicine
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models
- (2013) WENMIN HOU et al. ONCOLOGY REPORTS
- Risk Factors in the Development of Esophageal Adenocarcinoma
- (2012) Heiko Pohl et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice
- (2012) Jian-hua Gong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Regulation of ERBB2 Receptor by t-DARPP Mediates Trastuzumab Resistance in Human Esophageal Adenocarcinoma
- (2012) J. Hong et al. CANCER RESEARCH
- Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3
- (2012) Lei Zhao et al. Journal of Translational Medicine
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
- (2012) Xianhua Wu et al. Journal of Translational Medicine
- Phase I clinical trial of vaccination with URLC10-derived peptide for patients with advanced esophageal cancer
- (2012) Hajime Ishikawa et al. Esophagus
- Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma
- (2011) Tobias Lange et al. CANCER LETTERS
- VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression
- (2011) Pengfei Liu et al. CYTOKINE
- Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines
- (2011) Kousaku Mimura et al. INTERNATIONAL JOURNAL OF CANCER
- Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
- (2010) M. W. Pedersen et al. CANCER RESEARCH
- Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma
- (2010) Makoto Iwahashi et al. CANCER SCIENCE
- Effective Therapeutic Targeting of the Overexpressed HER-2 Receptor in a Highly Metastatic Orthotopic Model of Esophageal Carcinoma
- (2010) S. J. Gros et al. MOLECULAR CANCER THERAPEUTICS
- Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
- (2009) A. Talavera et al. CANCER RESEARCH
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- The biological properties of cetuximab
- (2008) Bruno Vincenzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now